Answers are grounded in this paper and cite their sources.
Influenza A (H7N9) emerged earlier this year as a health threat in China. Efforts to develop a vaccine are under way. This letter presents initial phase 1 clinical data on the safety and immunogenicity of a candidate vaccine.
No takes yet. Share an insight, caveat, or question.
Fries et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: